Skip to main content
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 129.33
Day High 130.75
Open:130.11
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

UM Names Anthony Plant EVP, Global President, J3
- PR Newswire - Mon Sep 16, 4:30PM CDT
PR Newswire - CMTX
Mon Sep 16, 4:30PM CDT
UM, the full-service marketing and media agency network of IPG Mediabrands, today announced the appointment of Anthony Plant to EVP, Global President of J3, UM's full-service dedicated media unit for Johnson & Johnson. Effective immediately, Plant will oversee the agency's largest global client, with a focus on advancing Johnson & Johnson's goals, plans and ambitions and implementing best-in-class media planning at the global, regional and local levels. Plant succeeds Eileen Kiernan, who was recently elevated to Global CEO, UM.
S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels
- PR Newswire - Mon Sep 16, 10:30AM CDT
PR Newswire - PRNW
Mon Sep 16, 10:30AM CDT
NEW YORK , Sept. 16, 2019 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") announced today that preliminary Q2 2019 S&P 500 ® stock buybacks , or share repurchases, were $164.5 billion . This was the second consecutive quarterly decline after four consecutive quarters of record buybacks. Q2 2019 buybacks were 20.1% lower than Q1 2019's $205.6 billion , 13.7% lower year-over-year from Q2 2018's $190.6 billion , and 26.2% lower than the Q4 2018 record expenditure of $223.0 billion .  
S&P 500 buybacks decline significantly in Q2 2019; expenditures still remain higher than the pre-2018 levels
- PR Newswire - Mon Sep 16, 10:30AM CDT
PR Newswire - CMTX
Mon Sep 16, 10:30AM CDT
S&P Dow Jones Indices ("S&P DJI") announced today that preliminary Q2 2019 S&P 500® stock buybacks, or share repurchases, were $164.5 billion. This was the second consecutive quarterly decline after four consecutive quarters of record buybacks. Q2 2019 buybacks were 20.1% lower than Q1 2019's $205.6 billion, 13.7% lower year-over-year from Q2 2018's $190.6 billion, and 26.2% lower than the Q4 2018 record expenditure of $223.0 billion.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 126.34 +2.53% increase
on 09/10/19
Period Open:131.36
Price movement based on the high, low and last over the given period.
132.66 -2.35% decrease
on 08/20/19
-1.82 (-1.39%) decrease
since 08/16/19
3-Month 126.34 +2.53% increase
on 09/10/19
Period Open:140.09
Price movement based on the high, low and last over the given period.
144.98 -10.65% decrease
on 06/25/19
-10.55 (-7.53%) decrease
since 06/14/19
52-Week 121.00 +7.06% increase
on 12/24/18
Period Open:139.49
Price movement based on the high, low and last over the given period.
148.99 -13.05% decrease
on 12/04/18
-9.95 (-7.13%) decrease
since 09/14/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).